Tech Company Financing Transactions
MindImmune Funding Round
MindImmune secured a $5 million funding round on 3/10/2026. Investors included Alzheimer's Drug Discovery Foundation.
Transaction Overview
Company Name
Announced On
3/10/2026
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to support completion of critical translational studies and IND submission, as well as strategic planning for early clinical development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
130 Flagg Road
Kingston, RI 02881
USA
Kingston, RI 02881
USA
Phone
Website
Email Address
Overview
MindImmune is developing novel therapies designed to stop neuroinflammatory disease progression, preserve neuronal connections and protect brain health so people can live with dignity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 3/10/2026: Factorial Energy venture capital transaction
Next: 3/10/2026: Esper Policy venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs